Anti-SARS-CoV-2 immunoadhesin remains effective against Omicron and other emerging variants of concern

por Cohen-Dvashi, Hadas, Weinstein, Jonathan, Katz, Michael, Eilon-Ashkenazy, Maayan, Mor, Yuval, Shimon, Amir, Achdout, Hagit, Tamir, Hadas, Israely, Tomer, Strobelt, Romano, Shemesh, Maya, Stoler-Barak, Liat, Shulman, Ziv, Paran, Nir, Fleishman, Sarel Jacob, Diskin, Ron
Publicado 2022